Oncology Diagnostics Panel Session
Kineticos recently hosted a panel with 3 industry veterans to gain insight regarding the nuances of the oncology diagnostics market. This third installment of the series discusses how the emergence of Immuno-Oncology has changed the Oncology Diagnostics landscape.
- Eric Mayer, CEO, EDP Biotech
- Sandra Dunn, CEO, Phoenix Molecular
- Brian Kelly, Global Director, Diagnostic Partnering, Thermo Fisher
Click here for a condensed and edited version of Part 3.